Is an IQCP required by CLIA?

Yes. CLIA permits an Individualized Quality Control Plan as an alternative to default QC rules when a laboratory documents a risk assessment and appropriate controls. Cite CLIA regulations and CMS guidance when selecting IQCP over default procedures.

Who must sign and approve the IQCP?

Typically the laboratory director or designated responsible official plus QA leadership must sign. Signatures should include printed name, title, and date to show accountability and meeting CLIA oversight expectations.

Can the IQCP be signed electronically?

Yes. Electronic signatures are acceptable when they meet ESIGN and UETA criteria: demonstrable intent, consent, attribution, and reliable record retention. For HIPAA-protected content ensure the platform supports required safeguards and a Business Associate Agreement when applicable.

How often must the IQCP be reviewed?

Review frequency is typically annual or whenever there is a method, instrument, or procedure change that affects QC. Document the review schedule and retain evidence of each review and approval.

What records must be retained with the IQCP?

Retain supporting QC data, corrective-action logs, maintenance records, and version history. Retention periods may be influenced by CLIA, HIPAA, and state rules; maintain reproducible copies for inspections.

What to do after a QC failure or incident?

Follow the IQCP corrective-action steps: contain affected results, perform root-cause analysis, document actions taken, notify stakeholders as required, and revise the IQCP if the failure reveals a gap in controls.

Electronic Signature
Templates
Healthcare
Healthcare IQCP Form

Healthcare IQCP Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE IQCP FORM

Facility Information

Facility Name Department / Laboratory Facility Address

Laboratory Contact: Phone:

Patient / Specimen Information (if applicable)

Patient Full Name

Date of Birth: Gender: Male Female Other

Patient Address

Phone: Emergency Contact:

Insurance & Clinical History

Insurance Provider

Policy Number

Group Number

Subscriber Name

Current Medications Known Allergies Prior Surgeries / Significant History Chronic Conditions

Test / Assay Information

Test / Assay Name

Specimen Type:

Collection Date/Time:

Manufacturer / Kit: Instrument:

Lot/Control Numbers:

IQCP Scope, Effective Dates, and Purpose

Scope: This Individualized Quality Control Plan (IQCP) documents the risk assessment, control measures, monitoring, and corrective actions applicable to the above listed test(s). The IQCP is implemented in accordance with applicable federal and state laboratory quality regulations and facility policy.

Effective Date:

Expiration / Review Date:

Purpose / Rationale for IQCP

Risk Assessment Summary (Process Steps & Failure Modes)

For each critical process step identify potential failure modes, likelihood, potential patient harm, and mitigations. Attach additional pages if needed.

Process Step 1 Process Step 2 Process Step 3

Quality Control Plan Elements

Quality Control Materials / Controls Control Frequency Acceptable Ranges / Limits Corrective Action Plan

Monitoring, Training, and Documentation

Monitoring Activities Personnel Training Requirements Recordkeeping and Audit Trail

Certifications, Notices, and Acknowledgment

Certification by Facility: The laboratory retains responsibility to implement and maintain the IQCP, including periodic review, corrective action documentation, and personnel competency. The laboratory's IQCP is designed to mitigate identified risks; it does not eliminate risk entirely. Test performance and results remain subject to the limitations of the assay and clinical interpretation.

Patient / Representative Acknowledgment: I acknowledge that I have been informed that testing for the above-listed test(s) will be performed under the facility's Individualized Quality Control Plan (IQCP). I understand that the IQCP addresses quality control and monitoring procedures for the laboratory performing the test and that the plan is maintained by the laboratory for regulatory compliance, quality assurance, and patient safety purposes.

Authorization: By signing below I authorize the laboratory to perform the testing described and to retain relevant specimens and quality records as required for quality assurance and regulatory compliance. I understand that test results will be provided to the ordering clinician and documented in my medical record. I understand my rights regarding confidentiality and may request clarification about the testing and IQCP from facility staff.

Patient Right to Withdraw: I understand that I may withdraw consent for testing prior to specimen processing. Withdrawal of consent does not affect use of results already reported or other lawful uses of specimens for quality and regulatory activities as required by the laboratory.

Patient Questions / Comments

Confirmation: I have received an explanation of the IQCP and the test procedure

Patient Printed Name:

Signature:

Relationship (if representative):

Date:

What the Healthcare IQCP Form Is and when it's used

The Healthcare IQCP Form documents an Individualized Quality Control Plan required for clinical laboratories performing testing under CLIA. It captures risk assessment, control measures, and quality control (QC) procedures specific to a test, instrument, or process. IQCPs establish how a laboratory meets CLIA performance requirements through tailored procedures rather than default QC rules. The form records responsible personnel, monitoring steps, corrective actions, and review schedules so regulators and accrediting bodies can verify that laboratory testing meets accepted quality standards.

Why a clear Healthcare IQCP Form matters

A well-prepared IQCP form documents risk mitigation, reduces inspection findings, and demonstrates compliance with CLIA requirements. It helps laboratories align daily practice with validated QC processes and shows external reviewers a repeatable approach to test performance and patient safety.

Who typically completes and reviews an IQCP

Laboratories and clinical testing programs prepare IQCPs to document test-specific quality control measures, then review them regularly.

Laboratory Directors and Managers responsible for CLIA compliance and final approval of the IQCP.
Quality Assurance personnel who draft risk assessments, monitor controls, and track corrective actions.
Clinical or technical staff who perform testing and maintain records for day-to-day QC execution.

Maintain a single authoritative IQCP form per test or instrument, and retain it with related QC records for regulatory review.

Core sections to include on a professional Healthcare IQCP Form

A compliant IQCP form organizes the plan into discrete sections so reviewers can quickly verify risk controls, responsibilities, and monitoring results during inspections or audits.

Identification

Test name, manufacturer/model, assay lot numbers, and CLIA test categorization. Include laboratory physical location and unique identifier for traceability during inspections or audits.

Risk Assessment

Systematic identification of potential failures, sources of analytic error, and their clinical impact. Describe likelihood, severity, and existing controls that reduce patient risk for this specific testing process.

Control Measures

Specific QC steps, frequencies, acceptance criteria, and calibration procedures. Include examples such as daily controls, external quality assessment participation, or instrument maintenance actions.

Monitoring and Documentation

Who records QC results, how often monitoring occurs, and the forms or electronic logs used. Cite responsible roles and required escalation procedures for out-of-range events or instrument failures.

Corrective Actions

Stepwise actions when QC fails: immediate containment, root-cause analysis, patient result review, and verification of corrective steps before resuming testing.

Review and Approval

Schedule for periodic review, signatures of approvers, and version control. Document evidence that leadership reviewed the IQCP and approved any revisions prior to implementation.

Required fields and minimum entries

Test Identifier: Test name or code

Device Info: Manufacturer/model

Risk Findings: Identified hazards

Controls: QC steps listed

Responsible Party: Name and title

Review Date: MM/DD/YYYY

Step-by-step: completing a Healthcare IQCP Form

Follow a consistent sequence to assemble an IQCP: identify the test, perform a risk assessment, define controls, document monitoring, assign responsibilities, and obtain approval.

01

1. Identify: Specify test, device, and location.
02

2. Assess: Document potential errors and impacts.
03

3. Implement: Define QC steps and frequencies.
04

4. Approve: Obtain signatures and set review date.

How the IQCP integrates into lab workflows

IQCP is a living document that guides daily QC and informs incident responses; it should integrate with existing LIS, maintenance logs, and EHR interfaces where applicable.

Document Source: Upload IQCP to the lab document control system.
Operational Use: Technicians follow QC steps during each testing shift.
Event Handling: Log failures and execute corrective workflows.
Periodic Review: QA reviews and signs off at scheduled intervals.

Digital workflow settings for IQCP management

Configure electronic workflows to ensure version control, approvals, and accessible audit trails for regulators and internal reviewers.

Field	Configuration
Version Control	Require unique version IDs and change log
Approval Routing	Role-based electronic sign-off order
Access Controls	Restrict edits to QA and lab managers
Audit Trail	Capture signer, timestamp, IP address

Digital signing and submission considerations

Use an eSignature platform that preserves audit trails, supports required authentication, and retains records in a reproducible format.

Authentication: Email, SMS, or multi-factor
Audit Trail: Timestamps and signer details
Storage: Encrypted at rest

Ensure the chosen solution can produce reproducible copies and meet applicable HIPAA and CLIA documentation expectations before e-submitting.

Typical timelines and review cadence for IQCPs

IQCPs require an initial approval and scheduled periodic review; timelines below reflect common practice and regulatory expectations for documentation and monitoring.

Initial Approval Date:

Document the date of the first approval (MM/DD/YYYY).

Annual Review:

Many labs review IQCPs annually unless method changes occur.

Event-Driven Update:

Revise immediately after an adverse QC event or method change.

Record Availability:

Make current IQCP available during inspections on request.

Retention Start:

Retention counts from creation or last effective date.

Regulatory risks of an incomplete or incorrect IQCP

Survey Deficiency: CLIA citation

Remediation Order: Corrective action required

Test Suspension: Limitations on testing

Civil Penalty: Monetary fines possible

Reputation Risk: Clinical trust affected

Patient Harm: Risk to safety

Common mistakes when preparing an IQCP Form

Using generic, non-test-specific controls instead of documenting controls tailored to the instrument and assay reduces the plan's regulatory defensibility.
Omitting responsible party names or failing to include signatures and dated approvals can lead to survey citations and delayed corrective actions.
Failing to link QC results and corrective action logs to the IQCP means reviewers cannot verify ongoing monitoring or determine if controls were effective.
Treating the IQCP as static rather than updating it after method changes or QC failures often results in nonconformance with CLIA expectations.

Typical eSignature vendor feature comparison for IQCP workflows

eSignature solutions differ by price, bulk-send limits, compliance features, and HIPAA support. The table below summarizes common vendor characteristics relevant to Healthcare IQCP Form workflows without asserting plan-level promotions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Healthcare examples: how organizations use IQCP forms

Real-world examples show how IQCP forms support compliance, speed incident response, and centralize QC oversight.

Fertility Clinic Adoption

A regional fertility center standardized IQCPs across locations to harmonize QC.

The clinic tied device models to specific control frequencies to reduce variance.
Standardized forms reduced audit preparation time, improved traceability during inspections, and helped clinical staff follow one validated process.

Reference Lab Scale-Up

A reference laboratory implemented electronic IQCPs for high-throughput assays to centralize reviews.

Central QA approved templates while local sites captured exceptions.
The electronic approach improved version control, made trending analysis easier, and ensured consistent corrective-action documentation across sites.

Frequently asked questions about the Healthcare IQCP Form

Answers to common questions about preparation, signatures, retention, and regulatory expectations for IQCPs.

Need help? Contact support

Is an IQCP required by CLIA?
Yes. CLIA permits an Individualized Quality Control Plan as an alternative to default QC rules when a laboratory documents a risk assessment and appropriate controls. Cite CLIA regulations and CMS guidance when selecting IQCP over default procedures.
Who must sign and approve the IQCP?
Typically the laboratory director or designated responsible official plus QA leadership must sign. Signatures should include printed name, title, and date to show accountability and meeting CLIA oversight expectations.
Can the IQCP be signed electronically?
Yes. Electronic signatures are acceptable when they meet ESIGN and UETA criteria: demonstrable intent, consent, attribution, and reliable record retention. For HIPAA-protected content ensure the platform supports required safeguards and a Business Associate Agreement when applicable.
How often must the IQCP be reviewed?
Review frequency is typically annual or whenever there is a method, instrument, or procedure change that affects QC. Document the review schedule and retain evidence of each review and approval.
What records must be retained with the IQCP?
Retain supporting QC data, corrective-action logs, maintenance records, and version history. Retention periods may be influenced by CLIA, HIPAA, and state rules; maintain reproducible copies for inspections.
What to do after a QC failure or incident?
Follow the IQCP corrective-action steps: contain affected results, perform root-cause analysis, document actions taken, notify stakeholders as required, and revise the IQCP if the failure reveals a gap in controls.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now